Downstream Processing Market Research Report—Global Forecast till 2027

Downstream Processing Market Information by By Technique (Cell Disruption, Solid-Liquid Separation, Clarification/Concentration, Purification Techniques, Formulation), By Product (Chromatography Columns & Resins, Filters, Membrane Adsorbers, other), By Application (Antibiotic Production, Hormone Production, Antibodies Production, Vaccine Production, Other), By End User ( Biopharmaceutical Manufacturers, Contract Manufacturing Organization, Other) Forcast till 2027

ID: MRFR/HC/9186-HCR | September 2021 | Region: Global | 120 pages

Downstream Processing Market Overview:


The global downstream processing market is expected to cross ~USD 61,174.53 million by 2027 at a CAGR of ~16.09%. Downstream processing refers to the series of operations required to derive pure and homogeneous protein products from biological materials such as cells, tissue culture fluid, or plant tissues.Downstream processing is one of the vital stepsin the manufacturing process for pharmaceuticals,biopharmaceuticals, industrial enzymes, and natural fragrance &flavor compounds. There is a high demand for the end products extracted by downstream processing, owing to its increasing application in biopharmaceutical products.Thus, the downstream processing market is anticipated to observe significant growth during the forecast period.


COVID-19 Analysis:


The rising prevalence of COVID-19 is projected to influence positively on market growth over the forecast period. As the coronavirus outbreak continues, the majority of pharmaceutical and biopharmaceutical companies experienced a significant loss, thereby hampering the downstream processing market. Many companies had restricted or halted their manufacturing and supply operations in the initial phase of the pandemic.In addition, the supply shortage of raw materials has further impacted the downstream processing market. Social distancing guidelines and resource reallocation in the course of the COVID-19 pandemic have led to significant disruption of pharmaceutical and biopharmaceutical industriesglobally.


However, owing to the increasing demand for the COVID-19 vaccine, there has been a sudden increase in demand for downstream processing products.The key players in the downstream processing market have increased their production to meet the demand for the products. For instance, In February 2021, Rentschler Biopharma, a Germany-based contract development and manufacturing organization (CDMO), announced the ramping up of the production of CVnCoV COVID-19 candidate vaccine by CureVac N.V. (Germany).Rentschler Biopharma (Germany)is responsible for manufacturing,downstream processing, and formulation of the vaccine.Furthermore, to avoid shortages for the necessary downstream processing products, theFood and Drug Administration (FDA) and European Commission proposed and published regulations focusing on-demand optimization and rational supply. These regulation revisions included several regulations to enhance imports to maintain integration of the supply chain.


Market Dynamics:


Drivers


  • Growing biopharmaceutical industry and increasing spending in medical research


In recent years, the biopharmaceutical industry has witnessed robust growth. Biopharmaceutical companies are involved in the development of various innovative and effective regenerative therapies, which are playing a vital role in the growth of the biopharmaceutical industry. Moreover, increasing public-private investments and R&D expenditure in biopharmaceutical &life science researchare further driving the growth of the biopharmaceutical industry, which is likely to propel the growth of the global downstream processing market in the coming years. For instance, according to Research!America, in 2018, total estimated theUS medical and health R&D expenditures accounted for about USD 194,175 million. Out of this, USD 129,488 million was invested by the industrysector,including biopharmaceutical and medical technology R&D firms, companies in the health care services arena, and others, and USD 43,016 million by the federal government.


Moreover, there was a 35.65% growth in the totalUS Medical and Health R&D expenditures between 2013 and 2018. Thus, the growing biopharmaceutical industry and increasing spending in medical research are anticipated to drive the growth in the downstream processing market.



  • Increasing number of CMOs in the market for downstream processing

  • Rising adoption of single-use technology in bioprocessing


Restraints



  • Shortage of skilled professionals


There isan impending shortage of trained professionals for the downstream processing industry. Bioprocess engineering is one of the core skills required forthe downstream processing industry. Owing to the increasing demand for biosimilars, an increasing number of Contract Manufacturing Organizations (CMOs) have entered the market. However, a shortage of skilled workforce is anticipated to restrain the market growth. The companies have to spend a significant amount of time training the staff with the necessary skills required for handling the operations. Furthermore, a high attrition rate in the bioprocessing industry is also anticipated to restrain the market growth.



  • Growing regulatory scrutiny on the cleaning validation of downstream purification processes


Opportunities



  • Advances in downstream processing


Technological advancements for downstream operations are crucial for maintaining efficiency and driving innovation in bioprocessing. Recent advances in downstream processing, including remote monitoring, membrane chromatography technology, single-use sensors, and data analytics, are anticipated to provide significant growth opportunities for the global downstream processing market. Furthermore, a rise in R&D activities in advanced bioprocess technologies has led to high-throughput process development and high-resolution membrane systems. Thus, advances in bioprocessing technologies are anticipated to provide significant growth opportunities for the market.



  • Increasing demand for monoclonal antibodies


Value Chain Analysis


The global downstream processing market is growing steadily due to the rising number of players coming forward with new and better products. The value chain analysis of the downstream processing market comprises four major components starting with the R&D and designing, followed by manufacturing the products, distribution & sales, and ends with post-sales services.


R&D and designing start with conceptualizing, followed by design, then development, and lastly, testing. The R&D segment comprises 25-30% of the value chain. After the product designs are final, the manufacturing of the product starts. Manufacturing consists of 45-50% of the value chain. The sourcing of raw material is the initial phase in the manufacturing of the products. The manufacturing components are sometimes outsourced. Outsourcing eliminates manufacturing process activities of some parts and helps to improve the efficiency of the process. Then comes distribution and sales, which is involved in creating awareness about the products to get interested customers for the product. It consists of 10-15% of the value chain. Lastly comes post-sales services, which account for around 5-10% of the value chain. In this step, customer feedback is taken into consideration to improve upon their existing product portfolio.


Segment Overview


By Technique



  • Cell Disruption


Cell disruption is the process of lysing of cells and is an importanttechnique in downstream processing related to the manufacturing of biological products. Cell disruption is used forthe extraction and retrieval of the desired products.Cell disruption includes several methods such as mechanical methods, non-mechanical methods, and chemical methods. The method used may vary depending on the type of cell and its cell wall composition.



  • Solid-Liquid Separation


Solid-liquid separation is one of the most common separation requirements in the downstream processingindustry, and many techniques are used,including sedimentation, centrifugation, filtration, and flocculation.



  • Clarification/Concentration


There are several techniques,including evaporation, liquid-liquid extraction, membrane filtration, precipitation, and adsorption,that are used to concentrate the desired biological products. The techniques are chosen based on the nature of the desired product and the cost factor.



  • Purification Techniques


Purification techniques can further be sub-segmented into Ion-Exchange chromatography, affinity chromatography, hydrophobic interaction chromatography, size exclusion chromatography, and others. Ion exchange chromatography is a process that separates ions and polar molecules based on their affinity to the ion exchanger. It works on almost any charged molecule, including small nucleotides, large proteins, and amino acids.Affinity chromatography is unique among separation methods as it is the only technique that permits the purification of proteins based on biological functions rather than individual physical or chemical properties.Hydrophobic interaction chromatography is a separation technique for purifying proteins while maintaining biological activity due to the use of conditions and matrices that operate under less denaturing conditions.Size-exclusion chromatography is a chromatographic method in which molecules in solution are separated by their size, and in some cases, molecular weight. Others include crystallization, sublimation, distillation, and other such purification techniques.The rising adoption of chromatography in the analysis of pharmaceutical drugs and its identification is fueling the growth of this segment.



  • Formulation


The formulationis the process that transitions a drug substance into a formulated drug product. This brings the product molecule into a form suitable for clinical administration.


By Product



  • Chromatography Columns &Resins


A chromatography column is a unit used in chromatography to separate chemical compounds. There isa wide range of products available for chromatography columns and resins.Several companies also provide customized products based on the requirement.



  • Filters


Filtration is a method of separating suspended particles from a liquid or gas using a porous medium thatretains the particles but allows the liquid or gas to pass through. A variety of filters are used, such asrotary vacuum filters, depth filters, plate frame filters, tangential filters, centrifugal filters and, surface filters.



  • Membrane Adsorbers


Membrane adsorbers are synthetic, thin, microporous, or macroporous membranes.There is a wide range of scalable formats available to be used in a variety of purification processes. Membrane adsorbers offer a cost-effective andflexible solution in antibody manufacturing and are gaining acceptance as an alternative to traditional resin-based chromatography,



  • Others


Other include filters, evaporators, centrifuges, and other downstream processing products


By Application



  • Antibiotic Production


Antibiotics are antimicrobial agents produced naturally by other microbes.Antibiotic production is one of the core applications of downstream processing.



  • Hormone Production


Hormone therapy has gained significantimportance in the medical field. Several of the hormones can be produced through downstream processing, including insulin.



  • Antibodies production


Antibody-based therapeuticsisone of the largest sectors of the biopharmaceutical industry. Increasing demand for antibody-based therapeutics is driving the market for antibodies production.



  • Vaccine Production


Owing to the current pandemic, several new market players have entered into vaccine production. Moreover, due to the imminent demand for the COVID-19 vaccine, all the key players have ramped up their production for vaccine production.



  • Others


Others include enzyme production, food-grade chemical production, nutraceutical productions, and other such applications.


By End User



  • Biopharmaceutical Manufacturers


The biopharmaceutical manufacturers segment is expected to hold the largest market share in 2021 due to increased R&D activities and biologics productionon a largescale, along with the rapidly growing biopharmaceutical industry.



  • Contract Manufacturing Organizations


The increasing number of contract manufacturing organizations and increasing demandfor biopharmaceuticals in pharma and biopharma companies through outsourcing activities is boosting the market growth.



  • Others


The other end users ofdownstream processing are research and academic institutes, medical device manufacturers industrial enzyme manufacturers.


By Region



  • North America:


The North American market accounted for the largest share in 2020, owing to the presence of well-established research organizations involved in research activities, the presence of a large number of CMOs, and pharmaceutical &biopharmaceutical companies. The presence of major market players in this region and their contribution through mergers& acquisitions and product launches is also boosting the market growth. North America is expected to continue dominating the global downstream processing market during the forecast period owing to a rise in R&D investments by public and private players in the healthcare sector.



  • Europe:


The European downstream processing market is driven by the rising R&D expenditure by biopharmaceutical companies, increasing investment in the R&D sector, and market players playing a significant role in contributing to the market growth. For instance, in November 2019, ThermoFisherScientific, Inc. announced that it is investing nearly USD 24 million in its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell culture media.In April 2020, Sartorius (Germany), a leading international partner of life science research and the biopharmaceutical industry, acquired selected life science businesses of Danaher Corporation (US). The acquisition will promote innovative protein analysis instruments, biosensors, and reagents that are used in drug discovery.



  • Asia-Pacific:


The Asia-Pacific downstream processing market is expected to be the fastest-growing due to rapidly growing and improving healthcare infrastructure, the establishment of research organizations, and increasing investments in biotechnology. In addition, factors such as theincreasing skilled workforce, growing biopharmaceutical industry, significant investments by key market players, and expanding R&D infrastructure are supporting the growth of this market. For instance, in Apri 2021, Asahi Kasei Corporation, a solution provider to the biologics manufacturing industry, expanded its business in China with the launch of  Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC), which will facilitate business expansion in China by localizing inventory management and order processing for shorter delivery times.



  • Rest of the World:


Rising per capita expenditure of the population in the healthcare sector and increasingadoption rate of the bioprocessing technology by biopharmaceutical companies, booming biotechnology sector, and advancements in chromatographic techniques are major factors contributing to the growth of the downstream processing market in this region.


Competitive Landscape


The downstream processing market is profitable, both for existing players as well as new entrants. A substantial level of rivalry is observed among the existing manufacturers in the market. Our analysis revealed that market players have adopted different strategies and innovative R&D techniques to expand their business and secure their position in the global downstream processing market. For instance, in April 2021, Thermo Fisher Scientific, Inc. (US) launched the Thermo Scientific KingFisher Apex Purification System. This system is a high-throughput sample purification instrument.


Thermo Fisher Scientific, Inc. has a robust industry experience and is one of the leading companies in the life science industry. Furthermore, a high customer satisfaction level, exceptional performance in new markets, and a strong product portfolio add to the company’s competitive advantage. The company also has a strong clientele and is well established in the industry. Also, it is continuously involved in seminars, conferences, and trade fairs in several countries to generate awareness about its products.


List of Key Companies Covered in this report:



  • Thermo Fisher Scientific Inc. (US)

  • Sartorius Stedim Biotech S.A. (France)

  • Merck Millipore (Germany)

  • Danaher Corporation (US)

  • 3M Company (US)

  • Boehringer Ingelheim (Germany)

  • Lonza Group AG (Switzerland)

  • Eppendorf AG (Switzerland)

  • Corning Incorporated (US)

  • Asahi Kasei Corporation (Japan)


Recent Developments



  • In July 2021, ThermoFisherScientific, Inc. (US) launched a set of solutions to support Adeno-associated Viral (AAV) manufacturing to decrease manufacturing costs and increase the viability of gene therapies as treatment options for patients. This included media panel, gene kit, and advanced purification resins.

  • In March 2020, Danaher Corporation (US) completed the acquisition of the Biopharma business of General Electric Company’s (US) Life Sciences division and rebranded it as Cytiva.

  • In 2019, Sartorius AG (France) entered into an agreement to acquire parts of Danaher’s Life Science portfolio, which complemented the portfolio of Sartorius’ laboratory and bioprocess business.


Report Overview:

The study covers the existing short-term and long-term market effects, as well as helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter’s Five Forces, Value Chain, and impact of COVID-19 on the market.

Scope of the Report


The scope of the global downstream processing market study includes a market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on technique, product, application, end user, and region.


Market Segmentation


Global Downstream Processing Market, by Technique



  • Cell Disruption

  • Solid-Liquid Separation

  • Clarification/Concentration

  • Purification Techniques

    • Ion Exchange

    • Affinity Exchange

    • Hydrophobic Interaction

    • Size Exclusion Chromatography

    • Others



  • Formulation


Global Downstream Processing Market, by Product



  • Chromatography Columns &Resins

  • Filters

  • Membrane Adsorbers

  • Others


Global Downstream Processing Market,by Application



  • Antibiotic Production

  • Hormone Production

  • Antibodies Production

  • Vaccine Production

  • Others


Global Downstream Processing Market, by End User



  • Biopharmaceutical Manufacturers

  • Contract Manufacturing Organizations

  • Research & Academic Institutes

  • Others


Global Downstream Processing Market, by Region



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    •  Japan

    •  India

    •  Australia

    •  South Korea

    •  Rest of Asia-Pacific



  • Rest of the World

    • Middle East&Africa

    • Latin America





Report Scope:
Report Attribute/Metric Details
  Market Size   2027:~USD 61,174.53Million
  CAGR   ~16.09%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2018&2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technique, Product, Application, End User, and Region
  Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
  Key Vendors   • Thermo Fisher Scientific Inc. (US) • Sartorius Stedim Biotech S.A. (France) • Merck Millipore (Germany) • Danaher Corporation (US) • 3M Company (US) • Boehringer Ingelheim (Germany) • Lonza Group AG (Switzerland) • Eppendorf AG (Switzerland) • Corning Incorporated (US) • Asahi Kasei Corporation (Japan)
  Key Market Opportunities   • Advances in downstream processing • Increasing demand for monoclonal antibodies
  Key Market Drivers   • Growing biopharmaceutical industry and increasing spending in medical research • Increasing number of CMOs in the market for downstream processing • Increasing adoption of single-use technology in bioprocessing


TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Regional Impact

5.3.4. Opportunity and Threat Analysis

6. GLOBAL DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE

6.1. Overview

6.2. Cell Disruption

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.3. Solid-Liquid Separation

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.4. Clarification/Concentration

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5. Purification Techniques

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5.1. Ion Exchange

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5.2. Affinity Exchange

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5.3. Hydrophobic Interaction

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5.4. Size Exclusion chromatography

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.5.5. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

6.6. Formulation

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7. GLOBAL DOWNSTREAM PROCESSING MARKET, BY PRODUCT

7.1. Overview

7.2. Chromatography Columns and Resins

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.3. Filters

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.4. Membrane Adsorbers

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

7.5. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8. GLOBAL DOWNSTREAM PROCESSING MARKET, BY APPLICATION

8.1. Overview

8.2. Antibiotic Production

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.3. Hormone Production

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.4. Antibodies Production

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.5. Vaccine Production

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

8.6. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

9. GLOBAL DOWNSTREAM PROCESSING MARKET, BY END USER

9.1. Overview

9.2. Biopharmaceutical Manufacturers

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

9.3. Contract Manufacturing Organizations

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

9.4. Others

Market Estimates & Forecast, by Region, 2018–2027

Market Estimates & Forecast, by Country, 2018–2027

10. GLOBAL DOWNSTREAM PROCESSING MARKET, BY REGION

10.1. Overview

10.2. North America

10.2.1. US

10.2.2. Canada

10.3. Europe

10.3.1. Germany

10.3.2. France

10.3.3. Italy

10.3.4. Spain

10.3.5. UK

10.3.6. Rest of Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Rest of the World

10.5.1. Middle East

10.5.2. Africa

10.5.3. Latin America

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Downstream Processing Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Downstream Processing Market

11.7. Key Developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger &Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income,2020

11.8.2. Major Players R&D Expenditure,2020

12. COMPANY PROFILES

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Products Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Sartorius Stedim Biotech S.A.

12.2.1. Company Overview

12.2.2. Products Offered

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Merck KGaA

12.3.1. Company Overview

12.3.2. Products Offered

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Danaher Corporation

12.4.1. Company Overview

12.4.2. Products Offered

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. 3M Company

12.5.1. Company Overview

12.5.2. Products Offered

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Boehringer Ingelheim

12.6.1. Company Overview

12.6.2. Products Offered

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Lonza Group AG

12.7.1. Company Overview

12.7.2. Products Offered

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. Eppendorf AG

12.8.1. Company Overview

12.8.2. Products Offered

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Corning Incorporated

12.9.1. Company Overview

12.9.2. Products Offered

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Asahi Kasei Corporation

12.10.1. Company Overview

12.10.2. Products Offered

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL DOWNSTREAM PROCESSING MARKET SYNOPSIS, 2018–2027

TABLE 2 GLOBAL DOWNSTREAM PROCESSING MARKET ESTIMATES &FORECAST, 2018–2027 (USD MILLION)

TABLE 3 GLOBAL DOWNSTREAM PROCESSING MARKET, BYTECHNIQUE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 8 NORTH AMERICA DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 10 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 11 US: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 12 US DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 13 US: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 14 US: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 15 CANADA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 16 CANADA DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2017–2027 (USD MILLION)

TABLE 17 CANADA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 18 CANADA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 19 EUROPE: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 20 EUROPE: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 21 EUROPE: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 22 EUROPE: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 23 GERMANY: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 24 GERMANY: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 25 GERMANY: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 26 GERMANY: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 27 UK: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 28 UK: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 29 UK: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 30 UK: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 31 FRANCE: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 32 FRANCE: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 33 FRANCE: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 34 FRANCE: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 ITALY: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 36 ITALY: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 37 ITALY: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 38 ITALY: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 39 SPAIN: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 40 SPAIN: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 41 SPAIN: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 42 SPAIN: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 43 REST OF EUROPE: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 44 REST OF EUROPE: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 45 REST OF EUROPE: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 46 REST OF EUROPE: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 48 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 49 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 50 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 51 INDIA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 52 INDIA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 53 INDIA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 54 INDIA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 55 CHINA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 56 CHINA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 57 CHINA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 58 CHINA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 59 JAPAN: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 60 JAPAN: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 61 JAPAN: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 62 JAPAN: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 63 AUSTRALIA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 64 AUSTRALIA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 65 AUSTRALIA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 66 AUSTRALIA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 67 SOUTH KOREA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 68 SOUTH KOREA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 69 SOUTH KOREA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 70 SOUTH KOREA: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 71 REST OF ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 72 REST OF ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 73 REST OF ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 74 REST OF ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 75 REST OF THE WORLD: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 76 REST OF THE WORLD: DOWNSTREAM PROCESSING MARKET, BY PRODUCT 2018–2027 (USD MILLION)

TABLE 77 REST OF THE WORLD: DOWNSTREAM PROCESSING MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 78 REST OF THE WORLD: DOWNSTREAM PROCESSING MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 79 MIDDLE EAST: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 80 MIDDLE EAST: DOWNSTREAM PROCESSING MARKET, BY PRODUCT 2018–2027 (USD MILLION)

TABLE 81 MIDDLE EAST: DOWNSTREAM PROCESSING MARKET, APPLICATION, 2018–2027 (USD MILLION)

TABLE 82 MIDDLE EAST: DOWNSTREAM PROCESSING MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 83 AFRICA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 84 AFRICA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT2018–2027 (USD MILLION)

TABLE 85 AFRICA: DOWNSTREAM PROCESSING MARKET, APPLICATION 2018–2027 (USD MILLION)

TABLE 86 AFRICA: DOWNSTREAM PROCESSING MARKET, END USER, 2018–2027 (USD MILLION)

TABLE 87 LATIN AMERICA: DOWNSTREAM PROCESSING MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 88 LATIN AMERICA: DOWNSTREAM PROCESSING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 89 LATIN AMERICA: DOWNSTREAM PROCESSING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 90 LATIN AMERICA: DOWNSTREAM PROCESSING MARKET, END USER, 2018–2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DOWNSTREAM PROCESSING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DOWNSTREAM PROCESSING MARKET

FIGURE 4 GLOBAL DOWNSTREAM PROCESSING MARKET SHARE, BY TECHNIQUE, 2020(%)

FIGURE 5 GLOBAL DOWNSTREAM PROCESSING MARKET SHARE, BY PRODUCT, 2020(%)

FIGURE 6 GLOBAL DOWNSTREAM PROCESSING MARKET SHARE, BY APPLICATION, 2020(%)

FIGURE 7 GLOBAL DOWNSTREAM PROCESSING MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL DOWNSTREAM PROCESSING MARKET SHARE, BY REGION, 2020(%)

FIGURE 9 NORTH AMERICA: DOWNSTREAM PROCESSING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 EUROPE: DOWNSTREAM PROCESSING MARKET SHARE, BY REGION, 2020(%)

FIGURE 11 ASIA-PACIFIC: DOWNSTREAM PROCESSING MARKET SHARE, BY REGION, 2020(%)

FIGURE 12 REST OF THE WORLD: DOWNSTREAM PROCESSING MARKET SHARE, BY REGION, 2020(%)

FIGURE 13 GLOBAL DOWNSTREAM PROCESSING MARKET: COMPANY SHARE ANALYSIS, 2020(%)

FIGURE 14 THERMO FISHER SCIENTIFIC INC.: KEY FINANCIALS

FIGURE 15 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 16 SARTORIUS STEDIM BIOTECH S.A.: KEY FINANCIALS

FIGURE 17 SARTORIUS STEDIM BIOTECH S.A.: SWOT ANALYSIS

FIGURE 18 MERCK KGAA: KEY FINANCIALS

FIGURE 19 MERCK KGAA:SWOT ANALYSIS

FIGURE 20 DANAHER CORPORATION: KEY FINANCIALS

FIGURE 21 DANAHER CORPORATION: SWOT ANALYSIS

FIGURE 22 3M COMPANY: KEY FINANCIALS

FIGURE 23 3M COMPANY: SWOT ANALYSIS

FIGURE 24 BOEHRINGER INGELHEIM: KEY FINANCIALS

FIGURE 25 BOEHRINGER INGELHEIM: SWOT ANALYSIS

FIGURE 26 LONZA GROUP AG: KEY FINANCIALS

FIGURE 27 LONZA GROUP AG: SWOT ANALYSIS

FIGURE 28 EPPENDORF AG: KEY FINANCIALS

FIGURE 29 EPPENDORF AG: SWOT ANALYSIS

FIGURE 30 CORNING INCORPORATED: KEY FINANCIALS

FIGURE 31 CORNING INCORPORATED: SWOT ANALYSIS

FIGURE 32 ASAHI KASEI CORPORATION: KEY FINANCIALS

FIGURE 33 ASAHI KASEI CORPORATION: SWOT ANALYSIS



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.